Cantor Fitzgerald analyst Sarah James initiated coverage of Molina Healthcare (MOH) with an Overweight rating and $354 price target. Molina is trading relatively inline with Centene (CNC) despite having an incrementally better win rate in 2021-2022 and lower risk to upcoming contract renewals in 2023-2024, the analyst tells investors in a research note. The firm believes Molina’s valuation does not account for its improved contract award performance and low incumbency risk in upcoming proposals.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MOH:
